Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID), 68252 [2014-26912]
Download as PDF
<![CDATA[
68252
Federal Register / Vol. 79, No. 220 / Friday, November 14, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention)
mstockstill on DSK4VPTVN1PROD with NOTICES
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10:30 a.m.–5:00 p.m.
Eastern Time, December 8, 2014.
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public, but
without a public comment period. The
public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcome to listen to the meeting by
joining the teleconference at the USA
toll-free, dial-in number 1–866–659–
0537 and the pass code is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort.
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and will expire on August 3, 2015.
Purpose: The Advisory Board is
charged with (a) providing advice to the
VerDate Sep<11>2014
17:37 Nov 13, 2014
Jkt 235001
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. The
Subcommittee for Dose Reconstruction
Reviews was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Discussed: The agenda
for the Subcommittee meeting includes
the following dose reconstruction
program quality management and
assurance activities: Discussion of
current findings from NIOSH and
Advisory Board dose reconstruction
blind reviews; discussion of dose
reconstruction cases under review
(cases involving Y–12, Oak Ridge
National Laboratory, Lawrence
Livermore National Laboratory,
Simonds Saw and Steel, Weldon Spring,
W.R. Grace, Westinghouse, International
Minerals and Chemical (IMC)
Corporation, Koppers Company,
Bridgeport Brass, Uranium Mill in
Monticello,); and preparation of the
Advisory Board’s next report to the
Secretary, HHS, summarizing the results
of completed dose reconstruction
reviews.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton
Road, Mailstop E–20, Atlanta, Georgia
30333, Telephone (513) 533–6800, Toll
Free 1(800)CDC–INFO, Email ocas@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–26912 Filed 11–13–14; 8:45 am]
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Office
of Infectious Diseases (BSC, OID)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 8:00 a.m.–5:00 p.m.,
December 10, 2014.
Place: CDC, Global Communications
Center, 1600 Clifton Road NE., Building 19,
Auditorium B3, Atlanta, Georgia 30333.
Status: The meeting is open to the public,
limited only by the space available.
Purpose: The BSC, OID, provides advice
and guidance to the Secretary, Department of
Health and Human Services; the Director,
CDC; the Director, OID; and the Directors of
the National Center for Immunization and
Respiratory Diseases, the National Center for
Emerging and Zoonotic Infectious Diseases,
and the National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, CDC, in
the following areas: Strategies, goals, and
priorities for programs; research within the
national centers; and overall strategic
direction and focus of OID and the national
centers.
Matters To Be Discussed: The meeting will
include reports from the BSC, OID working
groups; brief updates on priorities/activities
of CDC’s infectious disease national centers;
and a focused discussion on public health
issues arising from long-term outbreak
response efforts.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robin Moseley, M.A.T., Designated Federal
Officer, OID, CDC, 1600 Clifton Road NE.,
Mailstop D10, Atlanta, Georgia 30333,
Telephone: (404) 639–4461.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
BILLING CODE 4163–18–P
[FR Doc. 2014–26913 Filed 11–13–14; 8:45 am]
BILLING CODE 4163–19–P
PO 00000
Frm 00044
Fmt 4703
Sfmt 9990
E:\FR\FM\14NON1.SGM
14NON1
]]>Agencies
[Federal Register Volume 79, Number 220 (Friday, November 14, 2014)]
[Notices]
[Page 68252]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-26912]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Office of Infectious Diseases
(BSC, OID)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 8:00 a.m.-5:00 p.m., December 10, 2014.
Place: CDC, Global Communications Center, 1600 Clifton Road NE.,
Building 19, Auditorium B3, Atlanta, Georgia 30333.
Status: The meeting is open to the public, limited only by the
space available.
Purpose: The BSC, OID, provides advice and guidance to the
Secretary, Department of Health and Human Services; the Director,
CDC; the Director, OID; and the Directors of the National Center for
Immunization and Respiratory Diseases, the National Center for
Emerging and Zoonotic Infectious Diseases, and the National Center
for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the
following areas: Strategies, goals, and priorities for programs;
research within the national centers; and overall strategic
direction and focus of OID and the national centers.
Matters To Be Discussed: The meeting will include reports from
the BSC, OID working groups; brief updates on priorities/activities
of CDC's infectious disease national centers; and a focused
discussion on public health issues arising from long-term outbreak
response efforts.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Robin Moseley, M.A.T.,
Designated Federal Officer, OID, CDC, 1600 Clifton Road NE.,
Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639-4461.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2014-26912 Filed 11-13-14; 8:45 am]
BILLING CODE 4163-18-P
